Akash Rawat

Akash Rawat

Auto-generated profile, based on publicly available information

Akash Rawat

Himalayan Institute of Medical Sciences, Swami Rama Himalayan University, Dehradun, Uttarakhand, India

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2017 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
GPGarima Pandey
Garima Pandey
SGShyam Sundar Gupta
Shyam Sundar Gupta
ABAnil Bhatia
Anil Bhatia
OSO.P. Sidhu
O.P. Sidhu
ARA.K.S. Rawat
A.K.S. Rawat
CRCh V. Rao
Ch V. Rao

29 October 2010 in Journal of Liquid Chromatography & Related Technologies
Verified
Journal Article
Closed access
Amit SrivastavaAmit Srivastava
Amit Srivastava
STShashi Shankar Tiwari
Shashi Shankar Tiwari
SSSharad Srivastava
Sharad Srivastava
ARA. K. S. Rawat
A. K. S. Rawat
Objective of the present study was quantification of valerenic acid in rhizome of three plant species which is generally traded under the name of Jatamansi. A simple, rapid, cost-effective and accurate high performance thin layer chromatographic method has been developed for quantification of valerenic acid in Valeriana jatamansi, Nardostachys jatamansi, and Selinum vaginatum, which is one of the stable compounds and designated as a key marker compound. Separation and quantification of valerenic acid was achieved by HPTLC using ternary mobile phase of toluene: ethyl acetate: formic acid (80:20:5 v/v/v) on precoated silica gel 60F254 aluminum plate and densitometric determination was carried out in λ280 absorption-reflectance UV mode by deuterium lamp.

1 October 2020 in JPC – Journal of Planar Chromatography – Modern TLC
Verified
Journal Article
Closed access
PDF file
JDJyotsana Dwivedi
Jyotsana Dwivedi
AGAbhishek Gupta
Abhishek Gupta
SPSarvesh Paliwal
Sarvesh Paliwal
ARA. K. S. Rawat
A. K. S. Rawat

24 February 2026 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SBShreya Singh Beniwal
Shreya Singh Beniwal
YCYash Satish Caroicar
Yash Satish Caroicar
KPKashyapi Mbbs Patil
Kashyapi Mbbs Patil
ARAkash Rawat
Akash Rawat
ASAdam Sheikh Said
Adam Sheikh Said
ADAyush Dwivedi
Ayush Dwivedi
Periodontitis is a chronic inflammatory disorder that has been recognized as a significant public health concern worldwide. An imbalance between the protective oral microbiota and numerous oral pathogens has been implicated in its pathogenesis. Periodontitis not only impacts an individual’s oral health but also has systemic implications. The pathogenesis of periodontitis and these respiratory infections has been shown to be intricately linked. Numerous clinical research and animal studies have highlighted that the oral health of a population is closely related to their systemic health. It has been suggested that the periodontal pockets can act as a reservoir for oral pathogens, which can later migrate into the respiratory tract through aspiration or systemic circulation. This is a narrative review conducted after a wide literature search on databases such as PubMed, Cochrane, and Google Scholar with keywords including “Periodontitis,” “Respiratory,” “Infections,” “Tuberculosis,” ‘COVID-19’, “Pneumonia,” “Asthma,” and “COPD” published in the last 15 years. The cornerstone of this comprehensive review lies in deciphering the pathogenesis and epidemiology of periodontitis and how these periodontal bacteria contribute to respiratory infections through numerous biological mechanisms, inflammatory pathways, and the potential pathways of infection transmission. We also explore the empirical evidence through research studies supporting the periodontitis–respiratory infections link and also studies with conflicting or inconclusive results. By connecting the dots between this crucial oral–systemic link, we hope to uncover the gaps in the current research and find new avenues for developing cost-effective, targeted, transformative preventive and therapeutic strategies that will not only improve oral health but will also support respiratory health and help reduce the global burden of respiratory infections. Strengthening oral hygiene programs could reduce the burden of respiratory diseases, particularly in elderly and high-risk populations.

17 December 2025 in Endocrinology, Diabetes & Metabolism
Verified
Journal Article
Open access
SBShreya Singh Beniwal
Shreya Singh Beniwal
YJYujin Jeong
Yujin Jeong
ARAkash Rawat
Akash Rawat
MEMahmoud Einieh
Mahmoud Einieh
KPKashyapi Patil
Kashyapi Patil
AMAnuja Anil Mandavkar
Anuja Anil Mandavkar
Background: The global prevalence of diabetes mellitus (DM) is rising rapidly and is projected to reach unprecedented levels by 2035 and 2050, with a disproportionate burden among elderly populations and in low‐ and middle‐income countries. Diabetes‐related cardiovascular complications remain a leading cause of morbidity and mortality despite advances in glycaemic control and pharmacotherapy. There is an urgent need for novel molecular biomarkers and therapeutic targets to improve early detection, risk stratification, and personalised management. Methods: A comprehensive narrative review of the current literature was conducted to summarise emerging evidence on the biological roles of circular RNAs (circRNAs) in diabetes and its cardiovascular complications. Published experimental, translational, and clinical studies investigating circRNA expression, mechanisms of action, and therapeutic potential were critically analysed. Results: CircRNAs have emerged as key regulators in the pathophysiology of diabetes‐associated cardiovascular disorders, including diabetic cardiomyopathy, endothelial dysfunction, and vascular inflammation, as well as related microvascular complications. Mechanistically, circRNAs act through diverse pathways such as microRNA sponging, modulation of gene transcription, interaction with RNA‐binding proteins, and regulation of cellular processes including apoptosis, fibrosis, oxidative stress, and inflammation. Their covalently closed structure confers exceptional stability, while their tissue‐ and disease‐specific expression profiles support their utility as sensitive biomarkers for early diagnosis, prognosis, and therapeutic monitoring. Advances in synthetic circRNA design further highlight their promise as novel therapeutic agents, although challenges related to delivery efficiency, specificity, and off‐target effects remain. Conclusions: CircRNAs represent a promising class of biomarkers and therapeutic targets in diabetes‐related cardiovascular complications. Their stability, specificity, and functional versatility position them as attractive tools for precision medicine approaches in diabetes care. Further mechanistic studies and well‐designed clinical investigations are essential to translate circRNA‐based diagnostics and therapeutics into clinical practice.

30 May 2025 in Journal of Pediatric Rehabilitation Medicine
Verified
Journal Article
Open access
SBShreya Singh Beniwal
Shreya Singh Beniwal
NSNeetika Sharma
Neetika Sharma
MKMohammed Sulaiman Khan
Mohammed Sulaiman Khan
KJKrithi Pichiah John
Krithi Pichiah John
KGKopila Gyawali
Kopila Gyawali
ADAyush Dwivedi
Ayush Dwivedi
Multiple sclerosis (MS) is a chronic autoimmune condition causing damage to the protective covering of nerves in the central nervous system. Pediatric multiple sclerosis is a rare form of the disease that affects 3–5% of individuals with multiple sclerosis. Pediatric Onset Multiple Sclerosis (POMS) has a rather different clinical profile from the more prevalent adult multiple sclerosis. Alongside the classic symptoms of multiple sclerosis, children tend to present with various atypical symptoms that can impact motor milestones, speech development, and cognitive functions. This review aims to explore the pathogenesis, clinical features, diagnosis and progression of Pediatric Onset Multiple Sclerosis into adulthood, address the challenges accompanying this transition and identify strategies and therapies to overcome them. Pediatric multiple sclerosis patients transitioning into adulthood face many challenges, such as difficulty in school and social life, and dealing with uncertainties especially due to changes in healthcare providers from pediatric to adult settings. These challenges can be overcome by an emphasis on a well-structured transition plan, early planning, personalized care, proper counselling of the patient as well as the family and caretakers, a multidisciplinary approach with good communication and coordination between all healthcare personnel a robust support network with a gradual transition rather than an abrupt one. Proper care during the transition period is crucial to enhance patient adherence and deepen the understanding of the disease for both patients and their families. This will empower them to seek timely assistance when needed, reduce loss to follow-up, and ultimately improve overall quality of life.